Stemsation International Inc

PINK:STSN USA Drug Manufacturers - Specialty & Generic
Market Cap
$3.97 Million
Market Cap Rank
#50303 Global
#15358 in USA
Share Price
$0.01
Change (1 day)
+0.00%
52-Week Range
$0.01 - $0.01
All Time High
$0.35
About

Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. The company sells its products through business to business and direct to consumers channels. Stemsation International, Inc. was incorporated in 2006 and is headquartered in Plantation, Florida.

Stemsation International Inc (STSN) - Total Assets

Latest total assets as of March 2025: $12.99 Million USD

Based on the latest financial reports, Stemsation International Inc (STSN) holds total assets worth $12.99 Million USD as of March 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Stemsation International Inc - Total Assets Trend (2006–2024)

This chart illustrates how Stemsation International Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Stemsation International Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Stemsation International Inc's total assets of $12.99 Million consist of 3.0% current assets and 97.0% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 0.0%
Accounts Receivable $0.00 0.0%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $0.00 0.0%
Goodwill $0.00 0.0%

Asset Composition Trend (2006–2024)

This chart illustrates how Stemsation International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Stemsation International Inc's current assets represent 3.0% of total assets in 2024, a decrease from 92.7% in 2006.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 92.7% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 7.0% in 2006.
  • Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Stemsation International Inc Competitors by Total Assets

Key competitors of Stemsation International Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Stemsation International Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.01 - 2.70

Strong asset utilization - Stemsation International Inc generates 2.70x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -1300.16% - -41.01%

Negative ROA - Stemsation International Inc is currently not profitable relative to its asset base.

Stemsation International Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.24 0.06 0.00
Quick Ratio 0.24 0.06 0.00
Cash Ratio 0.00 0.00 0.00
Working Capital $-1.22 Million $ -696.78K $ -717.16

Stemsation International Inc - Advanced Valuation Insights

This section examines the relationship between Stemsation International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio -
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 30105.8%
Total Assets $12.99 Million
Market Capitalization $62.07 USD

Valuation Analysis

Below Book Valuation: The market values Stemsation International Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Stemsation International Inc's assets grew by 30105.8% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Stemsation International Inc (2006–2024)

The table below shows the annual total assets of Stemsation International Inc from 2006 to 2024.

Year Total Assets Change
2024-12-31 $12.99 Million +30105.83%
2023-12-31 $43.00K -27.41%
2022-12-31 $59.23K -25.26%
2021-12-31 $79.25K -1.47%
2020-12-31 $80.44K -41.24%
2019-12-31 $136.88K +7129275.00%
2018-12-31 $1.92 -99.92%
2017-12-31 $2.26K -99.31%
2010-12-31 $326.14K +4107.20%
2007-12-31 $7.75K -94.62%
2006-12-31 $144.03K --